Companies /Healthcare

OUTLOOK THERAPEUTICS INC

NASDAQ: OTLK Biotechnology
$0.64
â–² $0.00 (+0.59%) today
Markets closed · 8:49pm ET
Today · % change

Fundamentals

Market Cap
$155.6M
Revenue (TTM)
$-1,163,481
EPS (TTM)
$-0.70
52-Week Range
$0 – $3
Street Target
$4.90

About Outlook Therapeutics

Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company is headquartered in Cranbury, New Jersey.

OTLK Coverage